0000905148-16-001816.txt : 20160809
0000905148-16-001816.hdr.sgml : 20160809
20160809172520
ACCESSION NUMBER: 0000905148-16-001816
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160601
FILED AS OF DATE: 20160809
DATE AS OF CHANGE: 20160809
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001358762
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113651945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2801 GATEWAY DRIVE SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
BUSINESS PHONE: 972-865-2206
MAIL ADDRESS:
STREET 1: 2801 GATEWAY DRIVE SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Traweek James W JR
CENTRAL INDEX KEY: 0001665299
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37785
FILM NUMBER: 161819302
MAIL ADDRESS:
STREET 1: 2000 MCKINNEY AVE
STREET 2: SUITE 2125
CITY: DALLAS
STATE: TX
ZIP: 75201
4/A
1
form4.xml
X0306
4/A
2016-06-01
2016-06-01
0001358762
REATA PHARMACEUTICALS INC
RETA
0001665299
Traweek James W JR
C/O CPMG, INC.
2000 MCKINNEY AVE., SUITE 2125
DALLAS
TX
75201
true
Class A common stock
2016-06-01
4
P
0
802000
11
A
912969
I
See footnote
These shares of Class A common stock ("Shares") were inadvertently omitted from the Reporting Person's Form 4 filed June 1, 2016, and subsequent Forms 4.
These Shares were purchased in the Issuer's initial public offering, which closed on June 1, 2016.
These Shares are held in various funds for which CPMG, Inc. serves as investment manager. The Reporting Person is a co-director and co-shareholder of CPMG, Inc.
The Reporting Person disclaims beneficial ownership of the Shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
/s/ James W. Traweek, Jr.
2016-08-09